|
|
4350 La Jolla Village Drive, Suite 950
San Diego, CA 92122 USA
phone:1.858.373.1500
fax:1.858.373.7000
|
|
| Symbol |
MNOV |
| Exchange |
NASDAQ |
| Founded |
0 |
| Employees |
|
|
|
| www.medicinova.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Accelerating the global development and commercialization of pharmaceutical products. |
|
| Management |
| Yuichi Iwaki, M.D., Ph.D., Executive Chairman, President and Chief Executive Officer, and Founder; Richard E. Gammans, Ph.D., Chief Development Officer; Dr. Kenneth Locke, Chief Business Officer; Shintaro Asako, Vice President and Chief Financial Officer; Masatsune Okajima, Vice President and Head of Japanese Office; Lynn Terhorst, Vice President, Business Planning and Analysis; Kale Ruby, Director, Quality Assurance; Maria Feldman, Director, Regulatory Affairs |
| |
|
|
|
|
|
|
| |
|
|
|
|
| Keywords |
| premature labor, cancer, asthma, anxiety, disorders, pharmaceutical |
|
|
|
|
|
|
| Description |
|
MediciNova, Inc. is a privately held specialty pharmaceutical company focused on accelerating the global development and commercialization of innovative pharmaceutical products. |
|
| Technology / Differentiation |
| MediciNova's pipeline targets a variety of prevalent medical conditions, including premature labor, cancer, asthma and anxiety disorders. |
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members